Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sterling/Nycomed

Executive Summary

Sterling obtains option to license all new diagnostic imaging agents produced by Norwegian firm Nycomed over the next ten years. Agreement provides for licensing in U.S., Canada, and other "Sterling markets around the world." Sterling's Omnipaque (iohexol), introduced in 1986, and Amipaque (metrizamide) are both licensed from Nycomed.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS012221

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel